Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial

Recruiting

Phase 3

Radiation TherapyComparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial

Sponsor:

NRG Oncology

Code:

NCT06745024

Conditions

Metastatic Malignant Neoplasm in the Bone

Metastatic Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Best Practice

Biospecimen Collection

Bone Metastases Treatment

Computed Tomography

Conventional Radiotherapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-25. This information was provided to ClinicalTrials.gov by NRG Oncology on 2025-09-11.